-

Dr. Maurice O’Gorman to Speak on AAAS Webinar About Monitoring the Immune System as a Way to Fight COVID-19

original Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET. O’Gorman is Chief of Laboratory Medicine at CHLA and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. (Photo: Business Wire)

LOS ANGELES--(BUSINESS WIRE)--Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar about monitoring the immune system as a way to fight COVID-19 on Thursday, April 30, at noon ET.

He will be part of an expert panel of speakers that will also include Andrea Cossarizza, MD, PhD, Vice Dean of the School of Medicine at the University of Modena and Reggio Emilia in Italy, and President of the International Society for Advancement of Cytometry, and Lishomwa Ndhlovu, MBBS, PhD, a Professor of immunology at Weill Cornell Medicine in New York and Principal Investigator of the HIV and Emerging Pathogens Immunopathogenesis Laboratory.

Dr. O’Gorman, Chief of Laboratory Medicine at Children's Hospital Los Angeles and Professor of Pathology and Pediatrics at the Keck School of Medicine of USC, is an expert in immune monitoring and flow cytometry assays for the assessment of immune dysfunction. During this webinar, Dr. O’Gorman will discuss early results from labs around the world that have begun measuring CD4 and CD8 T-cell levels in peripheral blood as potential biomarkers for the prognosis of patients with COVID-19.

Decreased CD4 and CD8 cells means more severe disease.

Hospitals are observing that patients with severe cases of COVID-19 have significantly lower absolute numbers of CD4 and CD8 T-lymphocytes in their peripheral blood, compared to patients with mild or moderate disease. Low numbers of CD4 cells could potentially impact a patient’s ability to form antibodies against the virus, and low CD8 cells could diminish the patient’s ability to eliminate coronavirus from the body.

Dr. O’Gorman will discuss the potential role for routine measurement of CD4 and CD8 T-cells—a process called immunophenotyping—in hospitalized COVID-19 patients participating in clinical trials. Immunophenotyping may provide a tool for prognostics stratification of disease, and potentially as a way to monitor response to treatment.

Register for this Science/AAAS webinar here: https://www.sciencemag.org/custom-publishing/webinars/monitoring-immune-system-fight-covid-19-cd4-status-lymphopenia-and

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

Industry:

Children’s Hospital Los Angeles

Release Summary
CHLA's Maurice O’Gorman, PhD, MSc, will participate in an American Association for the Advancement of Science (AAAS) webinar.
Release Versions
English

Contacts

Contact for interviews with Dr. O’Gorman:
Lorenzo Benet
lbenet@chla.usc.edu
323-251-2847

More News From Children’s Hospital Los Angeles

Children’s Hospital Los Angeles Leads Region in Neurocritical NICU Care for Newborns

LOS ANGELES--(BUSINESS WIRE)--Subtle neurologic injury in newborns can be difficult to detect, but identifying this early is crucial in preventing further damage and supporting a baby’s lifelong brain development and brain health. To help protect the newborn brain, Children’s Hospital Los Angeles (CHLA) has integrated neurocritical care into its Level IV Steven & Alexandra Cohen Foundation Newborn and Infant Critical Care Unit (NICU) since 2013. One of only eight centers nationwide with ded...

Children’s Hospital Los Angeles Opens In-Hospital Family Pantry, Offering Nutritious Food and Expanding Access to Accept SNAP/EBT

LOS ANGELES--(BUSINESS WIRE)--Patient families and team members at Children’s Hospital Los Angeles (CHLA) who are eligible for the Supplemental Nutrition Assistance Program (SNAP) and the Electronic Benefits Transfer (EBT) system can now use their benefits to purchase fresh produce and other healthy food goods at CHLA's in-hospital Family Pantry. CHLA is the first pediatric medical institution in California to have SNAP/EBT nutrition assistance integrated into the hospital system. SNAP is a fed...

Children’s Hospital Los Angeles Launches New Era of Pediatric Medical Education With Establishment of the Chuck Lorre Pediatric Health Education Institute

LOS ANGELES--(BUSINESS WIRE)--Children’s Hospital Los Angeles (CHLA) is launching a new era of pediatric health care education with the appointment of Aarti Porwal, MHSA, as the inaugural Executive Director of the Chuck Lorre Pediatric Health Education Institute. She will lead a comprehensive enterprise-wide strategy to support education and training across CHLA, made possible by a transformational gift from The Chuck Lorre Family Foundation. “Children’s Hospital Los Angeles is a nationwide lea...
Back to Newsroom